Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Megan A Jacobi"'
Autor:
Richard L Cullum, Lauren M Lucas, Jared I Senfeld, John T Piazza, Logan T Neel, Kanupriya Whig, Ling Zhai, Mackenzie H Harris, Cristina C Rael, Darby C Taylor, Laura J Cook, David P Kaufmann, Christopher P Mill, Megan A Jacobi, Forrest T Smith, Mark Suto, Robert Bostwick, Ram B Gupta, Allan E David, David J Riese Ii
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243901 (2020)
Whereas recent clinical studies report metastatic melanoma survival rates high as 30-50%, many tumors remain nonresponsive or become resistant to current therapeutic strategies. Analyses of The Cancer Genome Atlas (TCGA) skin cutaneous melanoma (SKCM
Externí odkaz:
https://doaj.org/article/b577cffb2bf84042b2d2698e0a334423
Autor:
Lauren M. Lucas, Richard L. Cullum, Jessica A. Markham, Joelle N. Woggerman, Vipasha Dwivedi, Rania H. Mohamedelhassan, Laura J. Cook, Connor M. Kelley, Elizabeth L. Knerr, David P. Kaufmann, Megan A. Jacobi, Darby C. Taylor, Cristina C. Rael, Damien S. Waits, Taraswi M. Ghosh, Kenneth M. Halanych, Ram B. Gupta, David J. Riese
Metastatic skin cutaneous melanomas that contain wild-type BRAF alleles (“BRAF WT melanomas”) remain a significant clinical challenge, primarily because of the paucity of targets for therapeutic intervention. In prior work, in silico analyses of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56774191e9e618b913c9fdf142257902
https://doi.org/10.1101/2022.06.21.22276707
https://doi.org/10.1101/2022.06.21.22276707
Autor:
Laura J. Cook, Ram B. Gupta, Christopher P. Mill, Richard L. Cullum, Cristina C. Rael, Megan A. Jacobi, Logan Neel, Ling Zhai, Mark J. Suto, Allan E. David, Robert Bostwick, Jared I. Senfeld, Lauren M. Lucas, Forrest Smith, Kanupriya Whig, David J. Riese, Darby C. Taylor, Mackenzie H. Harris, John T. Piazza, David P. Kaufmann
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243901 (2020)
PLoS ONE
PLoS ONE
Whereas recent clinical studies report metastatic melanoma survival rates high as 30–50%, many tumors remain nonresponsive or become resistant to current therapeutic strategies. Analyses of The Cancer Genome Atlas (TCGA) skin cutaneous melanoma (SK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14095f21d952f219e3668ed10209735a
https://doaj.org/article/b577cffb2bf84042b2d2698e0a334423
https://doaj.org/article/b577cffb2bf84042b2d2698e0a334423